Back
Agios Pharmaceuticals Vs. Ciena Industry Stock Comparison
Sell
43
AGIO
Agios Pharmaceuticals
Last Price:
$39.06
Seasonality Move:
-3.22%
Buy
67
CIEN
Ciena
Last Price:
$77.75
Seasonality Move:
-7.92%
Sell
43
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
-
The current Agios Pharmaceuticals [AGIO] share price is $39.05. The Score for AGIO is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
AGIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $39.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AGIO is experiencing slight selling pressure.
CIEN Stock Price Chart
AGIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.58 | Buy |
Relative Strength Index (14 RSI): | 70 | Buy |
Chaikin Money Flow: | -64885 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.18 - 36.78) | Buy |
Bollinger Bands (100): | (28.39 - 34.67) | Buy |
CIEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 17.44 | Buy |
Relative Strength Index (14 RSI): | 49.29 | Sell |
Chaikin Money Flow: | 151428 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (73.29 - 80.25) | Buy |
Bollinger Bands (100): | (63.67 - 81.53) | Buy |
AGIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.87 | Buy |
20-day SMA: | 35.2 | Buy |
50-day SMA: | 32.5 | Buy |
200-day SMA: | 37.39 | Buy |
8-day EMA: | 37.26 | Buy |
20-day EMA: | 35.5 | Buy |
50-day EMA: | 33.51 | Buy |
200-day EMA: | 34.88 | Buy |
CIEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 79.42 | Sell |
20-day SMA: | 77.82 | Sell |
50-day SMA: | 77.54 | Buy |
200-day SMA: | 73.74 | Buy |
8-day EMA: | 49.73 | Buy |
20-day EMA: | 25.9 | Buy |
50-day EMA: | 11.61 | Buy |
200-day EMA: | 3.08 | Buy |
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $9.82 per share, a decrease next quarter of $0.00 per share, a decrease this year of $18.35 per share, and an increase next year of $0.84 per share.
Ciena Earnings Growth & CIEN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.37 per share, an increase this year of $0.32 per share, and an increase next year of $1.06 per share.
Agios Pharmaceuticals Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ciena Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |